申请人:Albany Molecular Research, Inc.
公开号:US07863271B2
公开(公告)日:2011-01-04
Compounds of formulae I, II and III:
are disclosed as 5-HT3 inhibitors. The compounds are useful in treating CINV, IBS-D and other diseases and conditions.
公式I、II和III的化合物被披露为5-HT3抑制剂。这些化合物在治疗化疗诱导恶心和呕吐、腹泻型肠易激综合征和其他疾病和病况方面有用。